How should Globus Medical balance the durability of its CREO spinal implants against their overall cost to manufacture?

Introduction

Balancing the durability of Globus Medical's CREO spinal implants against their manufacturing cost is a critical trade-off that impacts both patient outcomes and business sustainability. This scenario involves weighing long-term product performance against immediate financial considerations. I'll analyze this trade-off by examining product characteristics, stakeholder impacts, metrics, and potential experimental approaches.

Step 1

Clarifying Questions (3 minutes)

• Based on the medical device industry context, I'm thinking cost pressures might be significant. Could you provide insights into the current market dynamics and pricing pressures for spinal implants?

Why it matters: Helps understand the urgency of cost reduction efforts Expected answer: Increasing competition and healthcare cost containment efforts are putting pressure on margins Impact on approach: Would influence the balance between cost-cutting and maintaining premium positioning

• Considering patient outcomes, I'm assuming durability is crucial for avoiding revision surgeries. What's our current performance in terms of implant longevity compared to competitors?

Why it matters: Establishes a baseline for evaluating trade-offs Expected answer: CREO implants have above-average longevity, contributing to brand reputation Impact on approach: Would inform how much we can compromise on durability without losing competitive advantage

• From a technical perspective, I'm curious about our manufacturing processes. Are there emerging technologies or materials that could potentially improve durability while reducing costs?

Why it matters: Identifies potential win-win solutions Expected answer: Some promising new materials are in R&D, but not yet production-ready Impact on approach: Would guide investment decisions in manufacturing innovation

• Regarding our product portfolio, I'm wondering about the positioning of CREO implants. How do they fit into our overall product strategy and revenue mix?

Why it matters: Helps assess the strategic importance of this product line Expected answer: CREO is a flagship product, contributing significantly to revenue and brand reputation Impact on approach: Would influence the level of risk we're willing to take with changes

• Considering regulatory aspects, I'm thinking about FDA requirements. How might changes in durability or manufacturing processes impact our regulatory compliance and approval timelines?

Why it matters: Ensures we consider regulatory constraints in our decision-making Expected answer: Significant changes would require new clinical trials and FDA approval Impact on approach: Would affect the timeline and feasibility of implementing major changes